<DOC>
	<DOC>NCT00038545</DOC>
	<brief_summary>For patients with relapsed and refractory aggressive non-Hodgkin's lymphoma</brief_summary>
	<brief_title>A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>INCLUSION: Bidimensionally measurable current/refractory aggressive NHL (Diffuse lg cell, diffuse mixed cell, follicular lg noncleaved, immunoblastic, Ki1+ALCL, peripheral Tcell lymphoma, mantle cell lymphoma &amp; transformed lymphoma.) No more than 3 prior treatment regimens. No antilymphoma therapy within the past 3 weeks. Not be eligible for treatment of a higher priority. Performance status &lt;2 Zubrod, &gt; 60 Karnofsky. Good marrow reserve: ANC&gt;1.5 x 10(9)/L, platelets &gt; 100 x 10(9)/L. Bilirubin &lt;1.5mg/dL, SGOT, SGPT &lt; 2 x normal values. Serum creatinine &lt; 1.8 mg/dL. Age &gt; 18 yrs. Signed informed consent. Life expectancy of &gt; 12 weeks. No prior Taxane (paclitaxel or docetaxel), topotecan, or CPT11. No prior stem cell or bone marrow transplantation. No prior second malignancies except for basal cell carcinoma of the skin. EXCLUSION: Active or prior history of CNS lymphoma. Serious intercurrent medical illnesses requiring hospitalization. History of primary/secondary immunodeficiency (other than related to the malignant lymphoma because treatment is dependent on a functional immune system) or patients taking immunosuppressive drugs (systemic corticosteroids). Prior exposure to FilgrastimSD/01. Women who are pregnant or lactating. Participation in another clinical trial. Positive HIV antibody. History of prior sensitivity to E. coli derived products (such as filgrastim/neupogen).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>LYMPHOMA</keyword>
	<keyword>NON-HODGKINS</keyword>
	<keyword>AGGRESSIVE</keyword>
	<keyword>RELAPSED AND REFRACTORY</keyword>
</DOC>